Jung Sun Kim

机构：Seoul National University, Soonchunhyang University, CHA University Bundang Medical Center · ORCID：0000-0003-1132-5217

发表论文 20 篇 · 总被引 183 次 · h-index 5

代表论文

• TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer (2022 · European Journal of Cancer · 被引 62)
• Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer (2024 · Journal of Hepatology · 被引 51)
• Understanding the Social Mechanism of Cancer Misinformation Spread on YouTube and Lessons Learned: Infodemiological Study (2022 · Journal of Medical Internet Research · 被引 24)
• Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study (2025 · JHEP Reports · 被引 12)
• Prognostic Impact of Visceral Adipose Tissue Imaging Parameters in Patients with Cholangiocarcinoma after Surgical Resection (2024 · International Journal of Molecular Sciences · 被引 11)
• Prognostic Significance of Volumetric Parameters on Pretreatment FDG PET/CT in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab Therapy (2025 · Clinical Nuclear Medicine · 被引 4)